Apexium Financial’s HCA Healthcare HCA Stock Holding History

Apexium Financial’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,333	Closed	-$361K	–	248
2023 Q4	$361K	Buy	+1,333	New	+$329K	0.03%	201

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Apexium Financial's HCA Position: Q1 2024 in Review

Apexium Financial sold out of HCA Healthcare (HCA) in Q1 2024, closing a stake of 1,333 shares — an estimated $361K sold.

Apexium Financial first reported a position in HCA in Q4 2023 and held it in 1 quarter. The position peaked at $361K in Q4 2023. 1,126 funds tracked by Wall St. Rank hold HCA as of Q1 2024.

Apexium Financial reported no remaining HCA Healthcare position as of Q1 2024 after selling out during the quarter.
Apexium Financial sold 1,333 HCA Healthcare shares in Q1 2024, an estimated $361K.
Apexium Financial first reported a position in HCA Healthcare in Q4 2023 and held it in 1 quarter.
Apexium Financial's HCA Healthcare position peaked at $361K in Q4 2023.
1,126 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2024.

Based on Apexium Financial's 13F filing for Q1 2024, filed 19 Apr 2024.